Hussain SA - Search Results

1

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom.

Palmer DH, Hussain SA, Smith AJ, Hargreaves S, Ma YT, Hull D, Johnson PJ, Ross PJ. Palmer DH, et al. Among authors: hussain sa. Br J Cancer. 2013 Aug 20;109(4):888-90. doi: 10.1038/bjc.2013.410. Epub 2013 Jul 23. Br J Cancer. 2013. PMID: 23880824 Free PMC article.

2

Hepatocellular carcinoma.

Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P, Kerr DJ. Hussain SA, et al. Ann Oncol. 2001 Feb;12(2):161-72. doi: 10.1023/a:1008370324827. Ann Oncol. 2001. PMID: 11300318 Free article. Review.

3

Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.

Hussain SA, Ganesan R, Hiller L, Murray PG, el-Magraby MM, Young L, James ND. Hussain SA, et al. Br J Cancer. 2003 Feb 24;88(4):586-92. doi: 10.1038/sj.bjc.6600765. Br J Cancer. 2003. PMID: 12592374 Free PMC article.

4

Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.

Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Murray PG, Pastorek J, Young L, James ND. Hussain SA, et al. Oncol Rep. 2004 May;11(5):1005-10. Oncol Rep. 2004. PMID: 15069539

5

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DM, James ND. Hussain SA, et al. Br J Cancer. 2004 Jun 1;90(11):2106-11. doi: 10.1038/sj.bjc.6601852. Br J Cancer. 2004. PMID: 15150587 Free PMC article. Clinical Trial.

6

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.

Hussain SA, Stocken DD, Riley P, Palmer DH, Peake DR, Geh JI, Spooner D, James ND. Hussain SA, et al. Br J Cancer. 2004 Aug 31;91(5):844-9. doi: 10.1038/sj.bjc.6602112. Br J Cancer. 2004. PMID: 15292922 Free PMC article. Clinical Trial.

7

CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule.

Palmer DH, Hussain SA, Ganesan R, Cooke PW, Wallace DM, Young LS, James ND. Palmer DH, et al. Among authors: hussain sa. Oncol Rep. 2004 Oct;12(4):679-82. doi: 10.3892/or.12.4.679. Oncol Rep. 2004. PMID: 15375484

8

Systemic therapies for hepatocellular carcinoma.

Palmer DH, Hussain SA, Johnson PJ. Palmer DH, et al. Among authors: hussain sa. Expert Opin Investig Drugs. 2004 Dec;13(12):1555-68. doi: 10.1517/13543784.13.12.1555. Expert Opin Investig Drugs. 2004. PMID: 15566313 Review.

9

Endocrine therapy and other targeted therapies for metastatic breast cancer.

Hussain SA, Palmer DH, Moon S, Rea DW. Hussain SA, et al. Expert Rev Anticancer Ther. 2004 Dec;4(6):1179-95. doi: 10.1586/14737140.4.6.1179. Expert Rev Anticancer Ther. 2004. PMID: 15606341 Review.

10

Gene- and immunotherapy for hepatocellular carcinoma.

Palmer DH, Hussain SA, Johnson PJ. Palmer DH, et al. Among authors: hussain sa. Expert Opin Biol Ther. 2005 Apr;5(4):507-23. doi: 10.1517/14712598.5.4.507. Expert Opin Biol Ther. 2005. PMID: 15934829 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters